Free Trial

Compugen (CGEN) Short Interest Ratio & Short Volume

Compugen logo
$1.43 -0.01 (-0.69%)
(As of 11/20/2024 ET)

Compugen Short Interest Data

Compugen (CGEN) has a short interest of 1.27 million shares. This marks a -18.06% decrease in short interest from the previous month. The short interest ratio (days to cover) is 5.6, indicating that it would take 5.6 days of the average trading volume of 287,717 shares to cover all short positions.

Current Short Interest
1,270,000 shares
Previous Short Interest
1,550,000 shares
Change Vs. Previous Month
-18.06%
Dollar Volume Sold Short
$2.03 million
Short Interest Ratio
5.6 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
89,240,000 shares
Percentage of Shares Shorted
1.42%
Today's Trading Volume
228,086 shares
Average Trading Volume
287,717 shares
Today's Volume Vs. Average
79%
Short Selling Compugen?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Compugen and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CGEN Short Interest Over Time

CGEN Days to Cover Over Time

CGEN Percentage of Float Shorted Over Time

Compugen Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/20241,270,000 shares $2.03 million -18.1%N/A5.6 $1.60
10/15/20241,550,000 shares $2.53 million -17.1%N/A6.7 $1.63
9/30/20241,870,000 shares $3.38 million -0.5%N/A7.6 $1.81
9/15/20241,880,000 shares $3.70 million +15.3%N/A7.3 $1.97
8/31/20241,630,000 shares $3.42 million -5.8%N/A6.1 $2.10
8/15/20241,730,000 shares $3.13 million +3.0%N/A6 $1.81
7/31/20241,680,000 shares $2.97 million -4.0%N/A5 $1.77
7/15/20241,750,000 shares $3.34 million -0.6%N/A5.1 $1.91
6/30/20241,760,000 shares $2.96 million +0.6%N/A5.1 $1.68
6/15/20241,750,000 shares $3.62 million -3.3%N/A5.1 $2.07
5/31/20241,810,000 shares $3.93 million +4.6%N/A5 $2.17
5/15/20241,730,000 shares $3.82 million -11.3%N/A3.3 $2.21
4/30/20241,950,000 shares $3.76 million No ChangeN/A4 $1.93
4/15/20241,950,000 shares $3.82 million -6.7%N/A3.4 $1.96
3/31/20242,090,000 shares $5.39 million +11.8%N/A3.2 $2.58
3/15/20241,870,000 shares $5.11 million +2.2%N/A2.1 $2.73
2/29/20241,830,000 shares $4.72 million -9.4%N/A0.7 $2.58
2/15/20242,020,000 shares $4.69 million +23.9%2.4%0.8 $2.32
1/31/20241,630,000 shares $3.93 million +1.9%2.0%0.6 $2.41
1/15/20241,600,000 shares $2.88 million -24.5%1.9%0.6 $1.80
12/31/20232,120,000 shares $4.20 million +45.2%2.5%0.9 $1.98
12/15/20231,460,000 shares $1.10 million -3.3%1.8%0.6 $0.76
11/30/20231,510,000 shares $1.00 million +11.9%1.8%8.3 $0.66
11/15/20231,350,000 shares $832,815.00 -10.6%1.6%7.7 $0.62
10/31/20231,510,000 shares $1.15 million No Change1.8%6.2 $0.76
10/15/20231,510,000 shares $1.27 million -4.4%1.8%5.9 $0.84
9/30/20231,580,000 shares $1.47 million -3.7%1.9%5.5 $0.93
9/15/20231,640,000 shares $1.75 million -6.3%2.0%5.5 $1.07
8/31/20231,750,000 shares $2.00 million +12.2%2.1%4.6 $1.14
8/15/20231,560,000 shares $1.62 million -3.1%1.9%2.9 $1.04
7/31/20231,610,000 shares $1.87 million +3.9%2.0%3.3 $1.16
7/15/20231,550,000 shares $1.94 million -3.1%N/A3.3 $1.25
6/30/20231,600,000 shares $1.82 million +4.6%N/A3.5 $1.14
6/15/20231,530,000 shares $2.10 million -9.5%N/A3.4 $1.37
5/31/20231,690,000 shares $1.72 million -7.1%2.1%4.2 $1.02
5/15/20231,820,000 shares $1.48 million +2.8%2.2%6.6 $0.81
4/30/20231,770,000 shares $1.04 million -7.8%2.2%6.5 $0.59
4/15/20231,920,000 shares $1.22 million +1.6%2.4%5.4 $0.63
3/31/20231,890,000 shares $1.33 million -5.5%2.3%4.4 $0.70
3/15/20232,000,000 shares $1.51 million -4.3%2.4%4 $0.76
Breaking News: Tesla headed to $500… (Ad)

That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla.

So to claim your free digital copy today, simply follow this link and enter your email address. 
2/28/20232,090,000 shares $1.65 million +14.2%2.6%3.6 $0.79
2/15/20231,830,000 shares $1.47 million -2.1%2.2%2.9 $0.81
1/31/20231,870,000 shares $1.62 million -7.4%2.3%2.8 $0.87
1/15/20232,020,000 shares $2.14 million +2.5%2.5%2.8 $1.06
12/30/20221,970,000 shares $1.41 million -24.2%2.4%2.3 $0.72
12/15/20222,600,000 shares $2.17 million -2.3%3.2%3 $0.84
11/30/20222,660,000 shares $3.19 million -0.4%3.3%2.7 $1.20
11/15/20222,670,000 shares $2.31 million -1.1%3.3%2.6 $0.87
10/31/20222,700,000 shares $2.57 million -4.6%3.3%2.1 $0.95
10/15/20222,830,000 shares $2.16 million +28.6%3.5%2.2 $0.76
9/30/20222,200,000 shares $1.45 million +3.8%2.7%1.9 $0.66
9/15/20222,120,000 shares $2.23 million -22.3%2.6%1.9 $1.05
8/31/20222,730,000 shares $3.19 million -13.1%3.4%2.4 $1.17
8/15/20223,140,000 shares $4.62 million -6.0%3.9%3 $1.47
7/31/20223,340,000 shares $5.38 million -5.4%6.1%3.7 $1.61
7/15/20223,530,000 shares $6.60 million +5.1%6.5%4 $1.87
6/30/20223,360,000 shares $6.22 million -7.7%6.1%3.8 $1.85
6/15/20223,640,000 shares $6.08 million -11.7%6.7%4 $1.67
5/31/20224,120,000 shares $7.62 million -16.4%5.5%4.5 $1.85
5/15/20224,930,000 shares $9.51 million +11.3%6.6%5.3 $1.93
4/30/20224,430,000 shares $10.54 million +1.4%5.9%4.9 $2.38
4/15/20224,370,000 shares $11.41 million +4.8%5.8%4.6 $2.61
3/31/20224,170,000 shares $13.43 million -4.8%5.1%4.3 $3.22
3/15/20224,380,000 shares $12.79 million -28.6%5.4%4.4 $2.92
2/28/20226,130,000 shares $18.94 million +7.7%7.5%5.7 $3.09
2/15/20225,690,000 shares $18.32 million -1.7%7.2%5.4 $3.22
1/31/20225,790,000 shares $20.55 million +8.4%7.3%4.2 $3.55
1/15/20225,340,000 shares $20.77 million +3.7%6.8%4 $3.89
12/31/20215,150,000 shares $22.15 million -3.6%6.5%3.9 $4.30
12/15/20215,340,000 shares $22.75 million -10.7%6.8%4.1 $4.26
11/30/20215,980,000 shares $26.43 million +24.6%7.6%5.1 $4.42
11/15/20214,800,000 shares $26.16 million -11.3%6.1%4.3 $5.45
10/29/20215,410,000 shares $35.11 million -4.1%N/A7.5 $6.49
10/15/20215,640,000 shares $35.87 million -11.9%N/A8 $6.36
9/30/20216,400,000 shares $38.21 million -6.7%N/A9.2 $5.97
9/15/20216,860,000 shares $42.05 million -3.7%N/A9.6 $6.13
8/31/20217,120,000 shares $49.98 million -1.3%N/A8.9 $7.02
8/13/20217,210,000 shares $46.58 million +4.2%N/A8.2 $6.46
7/30/20216,920,000 shares $46.99 million -2.5%N/A7 $6.79
7/15/20217,100,000 shares $48.49 million -2.9%8.5%7.2 $6.83
6/30/20217,310,000 shares $60.53 million -6.4%8.7%7.2 $8.28
6/15/20217,810,000 shares $63.65 million +3.7%9.3%7.2 $8.15
5/28/20217,530,000 shares $57.83 million -3.3%9.0%6.5 $7.68
5/14/20217,790,000 shares $57.72 million +13.4%N/A5.5 $7.41
4/30/20216,870,000 shares $59.98 million -7.7%N/A5 $8.73
4/15/20217,440,000 shares $64.43 million -2.1%N/A5.4 $8.66
3/31/20217,600,000 shares $62.09 million +17.8%N/A5.2 $8.17
3/15/20216,450,000 shares $57.41 million +60.9%N/A4.4 $8.90
2/26/20214,010,000 shares $35.93 million +5.3%N/A2.8 $8.96
2/12/20213,810,000 shares $49.57 million -2.6%N/A3.1 $13.01
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)

Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…

1/29/20213,910,000 shares $46.92 million -6.5%N/A3.3 $12.00
1/15/20214,180,000 shares $56.47 million -5.0%N/A3.6 $13.51
12/31/20204,400,000 shares $56.80 million -6.2%N/A3.8 $12.91
12/15/20204,690,000 shares $60.59 million +73.1%N/A4.2 $12.92
11/30/20202,710,000 shares $35.23 million -8.1%N/A2.3 $13.00
11/15/20202,950,000 shares $39.80 million -20.3%N/A2.2 $13.49
10/30/20203,700,000 shares $50.14 million -4.4%N/A2.6 $13.55
10/15/20203,870,000 shares $67.65 million -41.7%N/A2.6 $17.48
9/30/20206,640,000 shares $107.90 million -0.8%N/A4.3 $16.25
9/15/20206,690,000 shares $115.40 million -3.2%N/A4.3 $17.25
8/31/20206,910,000 shares $119.47 million +12.7%N/A4.8 $17.29
8/14/20206,130,000 shares $105.44 million -8.2%N/A4.3 $17.20
7/31/20206,680,000 shares $96.26 million +5.5%N/A4.6 $14.41
7/15/20206,330,000 shares $92.23 million -1.4%N/A4.4 $14.57
6/30/20206,420,000 shares $96.43 million +9.9%N/A4.4 $15.02
6/15/20205,840,000 shares $86.78 million +32.1%N/A4.1 $14.86
5/29/20204,420,000 shares $68.02 million +16.0%N/A2.9 $15.39
5/15/20203,810,000 shares $46.82 million +28.7%N/A2.9 $12.29
4/30/20202,960,000 shares $42.89 million +14.7%N/A2.5 $14.49
4/15/20202,580,000 shares $29.54 million +49.1%N/A2.4 $11.45
3/31/20201,730,000 shares $25.69 million -55.8%N/A2 $14.85
3/13/20203,909,400 shares $35.18 million -8.2%N/A2.7 $9.00
2/28/20204,260,000 shares $26.63 million +7.3%N/A7.7 $6.25
2/14/20203,970,000 shares $46.21 million +20.3%N/A9.4 $11.64
1/31/20203,300,000 shares $27.89 million -2.1%N/A9.8 $8.45
1/15/20203,370,000 shares $30.03 million +0.9%N/A12.4 $8.91
12/31/20193,340,000 shares $22.04 million +9.2%N/A14.6 $6.60

CGEN Short Interest - Frequently Asked Questions

What is Compugen's current short interest?

Short interest is the volume of Compugen shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 1,270,000 shares of CGEN short. Learn More on Compugen's current short interest.

What is a good short interest ratio for Compugen?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CGEN shares currently have a short interest ratio of 6.0. Learn More on Compugen's short interest ratio.

Is Compugen's short interest increasing or decreasing?

Compugen saw a decline in short interest during the month of October. As of October 31st, there was short interest totaling 1,270,000 shares, a decline of 18.1% from the previous total of 1,550,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Compugen's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Compugen: Coherus BioSciences, Inc. (27.35%), Black Diamond Therapeutics, Inc. (11.19%), Inhibrx, Inc. (9.70%), C4 Therapeutics, Inc. (8.29%), iTeos Therapeutics, Inc. (11.11%), Mereo BioPharma Group plc (3.26%), Zevra Therapeutics, Inc. (7.53%), ProKidney Corp. (13.64%), REGENXBIO Inc. (9.91%), Terns Pharmaceuticals, Inc. (7.17%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Compugen stock?

Short selling CGEN is an investing strategy that aims to generate trading profit from Compugen as its price is falling. CGEN shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Compugen?

A short squeeze for Compugen occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CGEN, which in turn drives the price of the stock up even further.

How often is Compugen's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CGEN, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:CGEN) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners